CORAL GABLES, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MIAMI CANCER INSTITUTE AT BAPTIST HEALTH INC, founded in 2015, is a major nonprofit in the Diseases & Disorders sector that reported $112.9M in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion.
AS PART OF THE BAPTIST HEALTH NETWORK, THE MISSION OF MIAMI CANCER INSTITUTE AT BAPTIST HEALTH, INC IS TO IMPROVE THE HEALTH AND WELL-BEING OF INDIVIDUALS, AND TO PROMOTE THE SANCTITY AND PRESERVATION OF LIFE, IN THE COMMUNITIES WE SERVE. BAPTIST HEALTH IS A FAITH-BASED ORGANIZATION GUIDED BY THE SPIRIT OF JESUS CHRIST AND THE JUDEO-CHRISTIAN ETHIC. WE ARE COMMITTED TO MAINTAINING THE HIGHEST STANDARDS OF CLINICAL AND SERVICE EXCELLENCE, ENHANCED THROUGH TEACHING, RESEARCH AND INNOVATION, AND ROOTED IN THE UTMOST INTEGRITY AND MORAL PRACTICE. CONSISTENT WITH ITS SPIRITUAL FOUNDATION, BAPTIST HEALTH IS DEDICATED TO PROVIDING HIGH-QUALITY, COST-EFFECTIVE, COMPASSIONATE HEALTHCARE SERVICES TO ALL, REGARDLESS OF RELIGION, CREED, RACE OR NATIONAL ORIGIN, INCLUDING, AS PERMITTED BY ITS RESOURCES, CHARITY CARE TO THOSE IN NEED.
DURING 2023, THE INDIVIDUALS BELOW RECEIVED SEVERANCE PAYMENTS. SUCH AMOUNTS WERE TREATED AS TAXABLE COMPENSATION. - MARK DAVIS - $687,500 - MARGUERITE ROWELL - $43,425
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $112,935,556 | $102,141,214 | +0.1% |
| Expenses | $115,572,840 | $112,502,774 | +0.0% |
| Net Income | $-2,637,284 | $-10,361,560 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Albert Dotson Jr | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Bruce Beal | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Eduardo Vargas | Director | 2.0 |
Director
|
$0 | $0 | $2,500 |
| John H Dasburg | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| John Haley | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Jorge Rico | Director - Beg 01/2024 | 2.0 |
Director
|
$0 | $0 | $0 |
| P Michele Kessler | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Patrick P Lee | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Rev Dr William W White | Director | 2.0 |
Director
|
$0 | $0 | $3,183 |
| Richard Berkowitz | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Ronald A Shuffield | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Sadek Wahba | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Sandra Fuller | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Sherrill W Hudson | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Terry Perrin | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Alan A Gomez | VP of Finance - MCI & Physician Ops | 25.0 |
Officer
|
$0 | $118,136 | $574,184 |
| Michael Zinner MD | CEO | 50.0 |
Officer
|
$0 | $20,449 | $2,100,827 |
| Guenther Koehne | Dep Director | 50.0 |
Key Emp
|
$0 | $22,999 | $797,779 |
| Leonard Kalman MD | CMO | 10.0 |
Key Emp
|
$1,046,946 | $30,260 | $1,077,206 |
| Margarita Pons | VP | 50.0 |
Key Emp
|
$500,242 | $93,606 | $593,848 |
| Mark Davis | COO | 50.0 |
Key Emp
|
$1,968,330 | $129,762 | $2,098,092 |
| Minesh Mehta MD | Dir. Radiation Oncology | 50.0 |
Key Emp
|
$0 | $47,275 | $1,093,497 |
| Scott Lipkin | CRO | 50.0 |
Key Emp
|
$0 | $85,640 | $814,571 |
| Vicki Dian Caraway | VP Nursing | 50.0 |
Key Emp
|
$559,861 | $73,541 | $633,402 |
| Marguerite Rowell | AVP Nursing | 45.0 |
Highest
|
$307,479 | $35,789 | $343,268 |
| Maria A Suarez | AVP Nursing | 45.0 |
Highest
|
$264,542 | $31,994 | $296,536 |
| Maria B Currier | Physician | 45.0 |
Highest
|
$408,528 | $47,248 | $455,776 |
| Paul Lindeman | Medical Director | 45.0 |
Highest
|
$549,428 | $46,240 | $595,668 |
| Steven G Holan | VP | 45.0 |
Highest
|
$373,111 | $75,085 | $448,196 |
| Michele Ryder | Former COO/CNO | 0.0 |
|
$696,721 | $7,710 | $704,431 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $112,935,556 | $115,572,840 | $26,608,237 | $-2,637,284 |
| 2023 | $102,141,214 | $112,502,774 | $25,310,964 | $-10,361,560 |
| 2022 | $100,806,446 | $109,003,101 | $28,335,227 | $-8,196,655 |
| 2021 | $83,763,407 | $90,752,702 | $26,197,765 | $-6,989,295 |
| 2020 | $78,414,152 | $83,111,224 | $17,505,113 | $-4,697,072 |
| 2019 | $38,257,565 | $53,442,081 | $2,493,987 | $-15,184,516 |
| 2018 | $24,695,778 | $48,349,823 | $2,742,594 | $-23,654,045 |
Compare MIAMI CANCER INSTITUTE AT BAPTIST HEALTH INC with other nonprofits in Florida and across the country.